000			01935 a2200517 4500
005			20250517235624.0
264		0	_c20191113
008			201911s 0 0 eng d
022			_a2041-4889
024	7		_a10.1038/s41419-018-0964-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aVerlekar, Dattesh
245	0	0	_aCeramide synthase-6 confers resistance to chemotherapy by binding to CD95/Fas in T-cell acute lymphoblastic leukemia. _h[electronic resource]
260			_bCell death & disease _c09 2018
300			_a925 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aApoptosis _xphysiology
650	0	4	_aBiphenyl Compounds _xpharmacology
650	0	4	_aCaspase 8 _xmetabolism
650	0	4	_aCaspase Inhibitors _xpharmacology
650	0	4	_aCell Line
650	0	4	_aCell Line, Tumor
650	0	4	_aCeramides _xmetabolism
650	0	4	_aDrug Resistance, Neoplasm _xphysiology
650	0	4	_aHEK293 Cells
650	0	4	_aHumans
650	0	4	_aMembrane Proteins _xgenetics
650	0	4	_aNitrophenols _xpharmacology
650	0	4	_aOligopeptides _xpharmacology
650	0	4	_aPiperazines _xpharmacology
650	0	4	_aPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aProtein Binding
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors
650	0	4	_aRNA Interference
650	0	4	_aRNA, Small Interfering _xgenetics
650	0	4	_aSphingolipids _xmetabolism
650	0	4	_aSphingosine N-Acyltransferase _xgenetics
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_afas Receptor _xmetabolism
700	1		_aWei, Sung-Jen
700	1		_aCho, Hwangeui
700	1		_aYang, Shengping
700	1		_aKang, Min H
773	0		_tCell death & disease _gvol. 9 _gno. 9 _gp. 925
856	4	0	_uhttps://doi.org/10.1038/s41419-018-0964-4 _zAvailable from publisher's website
999			_c28826677 _d28826677